1 result for "Disarm Therapeutics, Inc."
Add this URL to any RSS reader. Updated daily.
Condensed Pyrazole Derivatives as Inhibitors of SARM1
The USPTO granted patent US12606558B2 to Disarm Therapeutics, Inc. covering condensed pyrazole derivatives useful as SARM1 inhibitors for treating and preventing axonal degeneration. The patent, granted April 21, 2026, contains 10 claims and names six inventors including Jonathan Bentley Jr. and Robert Owen Hughes.
Routine
Rule
Intellectual Property
Get alerts for "Disarm Therapeutics, Inc."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
75
AI Regulation
3
Banking & Finance
441
Consumer Protection
96
Courts & Legal
425
Data Privacy & Cybersecurity
95
Defense & National Security
53
Education
62
Energy
101
Environment
162
Gaming
2
Government & Legislation
447
Healthcare
15
Healthcare & Life Sciences
393
Immigration
10
Insurance
81
Labor & Employment
149
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
83
Securities & Markets
164
Tax
84
Telecom & Technology
48
Trade & Sanctions
141
Transportation
93
Get alerts for "Disarm Therapeutics, Inc."
We'll email you when new changes match "Disarm Therapeutics, Inc.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!